ProfileGDS4177 / 227682_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 80% 79% 81% 79% 65% 60% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated206.9180
GSM603099KU-812 non-treated192.3779
GSM603098KCL-22 Imatinib-treated241.1281
GSM603097KCL-22 non-treated197.7379
GSM603102JURL-MK1 Imatinib-treated70.8165
GSM603101JURL-MK1 non-treated53.1760